A tablet comprising of at least 50 % w/w valaciclovir, and 0.05 to 3 % w/w colloidal silicon dioxide is provided which has excellent hardness and friability properties while still maintaining good lubrication of the tablet granules.CARTER, BARRY, HOWARD...
1. Technical Result Prevention of cracks formation in valaciclovir tablets. 2. Essence A tablet comprising valaciclovir or the salts thereof in the form of granules, colloidal silicon dioxide, a filler and a lubricant; at least small part of the colloidal silicon dioxide, the filler and the lubr...
A tablet comprising of at least 50 % w/w valaciclovir, and 0.05 to 3 % w/w\ncolloidal silicon dioxide is provided which has excellent\nhardness and friability properties while still maintaining good lubrication of\nthe tablet granules.CARTER, BARRY HOWARD...
Date Jul. 25, 1996A tablet comprising at least 50% w/w valaciclovir and 0.05 to 3% w/w colloidal silicon dioxide in which the valaciclovir is present within granules of the tablets and the silicon dioxide, a lubricant and a microcrystalline cellulose filler are present extragranularly has ...
(57)< Abstract > At least, including 50% (weight/weight) barashikurobiru, and 0.05 - 3% (weight/weight) colloid two silicon oxides, being the tablet which becomes, the hardness which is superior and it possesses property easily, it offers the tablet at the same time containment the ...
A tablet comprising of at least 50 % w/w valaciclovir, and 0.05 to 3 % w/w colloidal silicon dioxide is provided which has excellent hardness and friability properties while still maintaining good lubrication of the tablet granules.CARTER, BARRY HOWARD...
A tablet comprising of at least 50 % w/w valaciclovir, and 0.05 to 3 % w/w colloidal silicon dioxide is provided which has excellent\nhardness and friability properties while still maintaining good lubrication of the tablet granules.CARTER, BARRY, HOWARD...
Date Jul. 25, 1996A tablet comprising at least 50% w/w valaciclovir and 0.05 to 3% w/w colloidal silicon dioxide in which the valaciclovir is present within granules of the tablets and the silicon dioxide, a lubricant and a microcrystalline cellulose filler are present extragranularly has ...
Date Jul. 25, 1996A tablet comprising at least 50% w/w valaciclovir and 0.05 to 3% w/w colloidal silicon dioxide in which the valaciclovir is present within granules of the tablets and the silicon dioxide, a lubricant and a microcrystalline cellulose filler are present extragranularly has ...
Date Jul. 25, 1996A tablet comprising at least 50% w/w valaciclovir and 0.05 to 3% w/w colloidal silicon dioxide in which the valaciclovir is present within granules of the tablets and the silicon dioxide, a lubricant and a microcrystalline cellulose filler are present extragranularly has ...